Brain Tumor Outcome Studies

J. Gregory Cairncross, David R. Macdonald, Successful chemotherapy for recurrent malignant oligodendroglioma Annals of Neurology. ,vol. 23, pp. 360- 364 ,(1988) , 10.1002/ANA.410230408

Sarel J. Vorster, Gene H. Barnett, A proposed preoperative grading scheme to assess risk for surgical resection of primary and secondary intraaxial supratentorial brain tumors. Neurosurgical Focus. ,vol. 4, ,(1998) , 10.3171/FOC.1998.4.6.5

Vivek H. Murthy, Harlan M. Krumholz, Cary P. Gross, Participation in Cancer Clinical Trials JAMA. ,vol. 291, pp. 2720- 2726 ,(2004) , 10.1001/JAMA.291.22.2720

Paul D. Brown, Karla V. Ballman, Teresa A. Rummans, Matthew J. Maurer, Jeff A. Sloan, Bradley F. Boeve, Lalit Gupta, David F. Tang-Wai, Robert M. Arusell, Matthew M. Clark, Jan C. Buckner, Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. Journal of Neuro-oncology. ,vol. 76, pp. 283- 291 ,(2006) , 10.1007/S11060-005-7020-9

Jules M. Nazzaro, Edward A. Neuwelt, The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. Journal of Neurosurgery. ,vol. 73, pp. 331- 344 ,(1990) , 10.3171/JNS.1990.73.3.0331

Jan H.M. Schellens, Phase 0 (zero) clinical trials: more than zero benefit? European Journal of Cancer. ,vol. 45, pp. 728- 729 ,(2009) , 10.1016/J.EJCA.2009.01.022

Martin M. Oken, Richard H. Creech, Douglass C. Tormey, John Horton, Thomas E. Davis, Eleanor T. McFadden, Paul P. Carbone, Toxicity and response criteria of the Eastern Cooperative Oncology Group American Journal of Clinical Oncology. ,vol. 5, pp. 649- 655 ,(1982) , 10.1097/00000421-198212000-00014

Phil Edwards, Janice Fernandes, Ian Roberts, Nathan Kuppermann, Young men were at risk of becoming lost to follow-up in a cohort of head-injured adults Journal of Clinical Epidemiology. ,vol. 60, pp. 417- 424 ,(2007) , 10.1016/J.JCLINEPI.2006.06.021

H. Michael Arrighi, Irva Hertz-Picciotto, The evolving concept of the healthy worker survivor effect Epidemiology. ,vol. 5, pp. 189- 196 ,(1994) , 10.1097/00001648-199403000-00009

Robert A. Lustig, Charles B. Scott, Walter J. Curran, Does Stereotactic Eligibility for the Treatment of Glioblastoma Cause Selection Bias in Randomized Studies American Journal of Clinical Oncology. ,vol. 27, pp. 516- 521 ,(2004) , 10.1097/01.COC.0000135641.82026.C4